COVID-19 Vaccine Hesitancy Among Patients With Breast Cancer

JAMA Oncology

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 10, 2021

Media advisory: The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.1962?guestAccessKey=8716f8b1-300f-49b4-be0c-ee2d9ff191a6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=061021

 

What The Study Did: This survey study among women with breast cancer in Mexico evaluates their specific concerns about and high hesitancy rate toward COVID-19 vaccination.

Authors: Cynthia Villarreal-Garza, M.D., D.Sc., of the Breast Cancer Center, Hospital Zambrano Hellion TecSalud in Nuevo León, Mexico, is the corresponding author.

 

(doi:10.1001/jamaoncol.2021.1962)

Editor’s Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.